Subclinical organ damage and cardiovascular risk prediction

Blood Pressure

Volumn 19, Issue 3, 2010, Pages 132-139

  Sehestedt, Thomas ^a   Olsen, Michael H ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cardiovascular risk; Hypertension; Risk stratification; Subclinical organ damage

Indexed keywords

ALBUMIN; CREATININE;

ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; BLOOD VESSEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CORNELL VOLTAGE PRODUCT; CREATININE BLOOD LEVEL; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; ELECTROCARDIOGRAM; ELECTRON BEAM TOMOGRAPHY; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INTRAVASCULAR ULTRASOUND; KIDNEY INJURY; MEDICAL INFORMATION; MICROALBUMINURIA; MODIFICATION OF DIET IN RENAL DISEASE; ORGAN INJURY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SOKOLOW LYON VOLTAGE; SUBCLINICAL ORGAN DAMAGE;

BIOLOGICAL MARKERS; CARDIOVASCULAR SYSTEM; HUMANS; HYPERTENSION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 77952801722     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2010.483054     Document Type: Article

References (56)

1. Magnus P, Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: Time to end the "only- 50%" myth. Arch Intern Med. 2001;161:2657-2660.
2. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, et al. Low risk-factor profi le and long-term cardiovascular and noncardiovascular mortality and life expectancy: Findings for 5 large cohorts of young adult and middle-aged men and women. JAMA. 1999;282: 2012-2018.
3. Law MR, Wald NJ, Morris JK. The performance of blood pressure and other cardiovascular risk factors as screening tests for ischaemic heart disease and stroke. J Med Screen. 2004;11:3-7.
4. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) fi nal report. Circulation. 2002;106: 3143-3421.
5. Mancia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
6. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfi eld MJ, et al. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens. 2009 Oct 15.
7. Bombelli M, Facchetti R, Carugo S, Madotto F, Arenare F, Quarti-Trevano F, et al. Left ventricular hypertrophy increases cardiovascular risk independently of in-offi ce and out-of-offi ce blood pressure values. J Hypertens. 2009;27: 2458-2464.
8. Woythaler JN, Singer SL, Kwan OL, Meltzer RS, Reubner B, Bommer W, et al. Accuracy of echocardiography versus electrocardiography in detecting left ventricular hypertrophy: Comparison with postmortem mass measurements. J Am Coll Cardiol. 1983;2:305-311
9. Myerson SG, Montgomery HE, World MJ, Pennell DJ. Left ventricular mass: Reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension. 2002;40:673-678.
10. Verdecchia P, Angeli F, Cavallini C, Mazzotta G, Repaci S, Pede S, et al. The voltage of R wave in lead aVL improves risk stratifi cation in hypertensive patients without ECG left ventricular hypertrophy. J Hypertens. 2009;27:1697-1704.
11. Li Z, Dahlof B, Okin PM, Kjeldsen SE, Wachtell K, Ibsen H, et al. Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: The Losartan Intervention For Endpoint Reduction in Hypertension study. J Hypertens. 2008;26: 1244-1249.
12. Schillaci G, Pirro M, Ronti T, Gemelli F, Pucci G, Innocente S, et al. Prognostic impact of prolonged ventricular repolarization in hypertension. Arch Intern Med. 2006;166:909-913
13. Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, et al. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: The Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE). Circulation. 2009;119: 1883-1891.
14. Havranek EP, Emsermann CD, Froshaug DN, Masoudi FA, Krantz MJ, Hanratty R, et al. Thresholds in the relationship between mortality and left ventricular hypertrophy defi ned by electrocardiography. J Electrocardiol. 2008;41:342-350.
15. Zanchetti A, Cuspidi C, Comarella L, Rosei EA, Ambrosioni E, Chiariello M, et al. Left ventricular diastolic dysfunction in elderly hypertensives: Results of the APROS-diadys study. J Hypertens. 2007;25:2158-2167.
16. Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse MK, et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens. 2005;23:183-191
17. Sundstrom J, Lind L, Arnlov J, Zethelius B, Andren B, Lithell HO. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation. 2001;103:2346-2351.
18. Okin PM, Roman MJ, Lee ET, Galloway JM, Howard BV, Devereux RB. Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: The Strong Heart Study. Hypertension. 2004;43:769-774.
19. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intimamedia thickness: A systematic review and meta-analysis. Circulation. 2007;115:459-467.
20. Johnsen SH, Mathiesen EB, Joakimsen O, Stensland E, Wilsgaard T, Lochen ML, et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: A 6-year follow-up study of 6226 persons: The Tromso Study. Stroke. 2007;38:2873-2880.
21. Touboul PJ, Labreuche J, Vicaut E, Amarenco P. Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke. 2005;36: 1741-1745.
22. Zanchetti A, Hennig M, Hollweck R, Bond G, Tang R, Cuspidi C, et al. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: Findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation. 2009;120:1084-1090.
23. Johnsen SH, Mathiesen EB. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep. 2009;11:21-27.
24. Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD. 3D ultrasound measurement of change in carotid plaque volume: A tool for rapid evaluation of new therapies. Stroke. 2005;36:1904-1909.
25. Laurent S, Cockcroft J, Van BL, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J. 2006;27:2588-2605.
26. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA. 2008;300:197-208.
27. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336-1345.
28. Part 4. Defi nition and classifi cation of stages of chronic kidney disease. Am J Kidney Dis. 2002;39(2, Supplement 1): S46-S75.
29. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffi th JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307-1315.
30. Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, et al. Mild renal insuffi ciency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int. 2002;62:1402-1407.
31. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Defi nition and classifi cation of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67: 2089-2100.
32. Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the Modifi cation of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis. 2004;44:84-93.
33. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
34. Ruilope LM, Zanchetti A, Julius S, McInnes GT, Segura J, Stolt P, et al. Prediction of cardiovascular outcome by estimated glomerular fi ltration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. J Hypertens. 2007;25:1473-1479.
35. Cirillo M, Anastasio P, De Santo NG. Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant. 2005;20:1791-1798.
36. Cirillo M, Lanti MP, Menotti A, Laurenzi M, Mancini M, Zanchetti A, et al. Defi nition of kidney dysfunction as a cardiovascular risk factor: Use of urinary albumin excretion and estimated glomerular fi ltration rate. Arch Intern Med. 2008;168:617-624.
37. Olsen MH, Wachtell K, Ibsen H, Lindholm LH, Dahlof B, Devereux RB, et al. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: The LIFE study. J Hypertens. 2006;24:775-781.
38. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension. 2000;35: 898-903.
39. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928-935.
40. Pencina MJ, D'Agostino RB, Sr., D'Agostino RB, Jr., Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassifi cation and beyond. Stat Med. 2008;27:157-172.
41. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De BG, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J. 2003;24:987-1003.
42. Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H, et al. Risk stratifi cation with the risk chart from the European Society of Hypertension compared with SCORE in the general population. J Hypertens. 2009;27:2351-2357.
43. Sehestedt T, Jeppesen J, Hansen TW, Wachtell K, Ibsen H, Torp-Petersen C, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2009;Dec 23.
44. Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, et al. Coronary artery calcifi cation compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: The Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med. 2008;168: 1333-1339.
45. Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H, et al. Which markers of subclinical organ damage to measure in individuals with high normal blood pressure? J Hypertens. 2009;27:1165-1171.
46. Diamond GA, Kaul S. The things to come of SHAPE: Cost and effectiveness of cardiovascular prevention. Am J Cardiol. 2007;99:1013-1015.
47. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, et al. From vulnerable plaque to vulnerable patient-Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98:2H-15H.
48. Waugh N, Black C, Walker S, McIntyre L, Cummins E, Hillis G. The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: Systematic review. Health Technol Assess. 2006;10:iii-x, 1.
49. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, et al. ACCF/AHA. 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: A report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the. 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation. 2007;115:402-426.
50. Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, et al. Emerging risk factors for coronary heart disease: A summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:496-507.
51. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study. Hypertension. 2005;45:198-202. (Pubitemid 40179960)
52. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Prognostic signifi cance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350-2356.
53. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004;292:2343-2349.
54. O'Malley PG, Feuerstein IM, Taylor AJ. Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: A randomized controlled trial. JAMA. 2003;289: 2215-2223.
55. Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Budoff MJ. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006;185:394-399.
56. Orakzai RH, Nasir K, Orakzai SH, Kalia N, Gopal A, Musunuru K, et al. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in benefi cial lifestyle behaviors. Am J Cardiol. 2008; 101:999-1002.